US Broker Ratings

RxSight, Inc. (RXST) Stock Analysis: Navigating Growth Potential Amidst a 32.85% Upside Target

For investors seeking opportunities in the healthcare sector, RxSight, Inc. (NASDAQ: RXST) offers a compelling narrative, especially with a potential upside of 32.85% based on analyst..

Talkspace, Inc. (TALK) Stock Analysis: Unpacking the 31.93% Potential Upside for Investors

Investors seeking exposure in the burgeoning field of virtual healthcare might find Talkspace, Inc. (NASDAQ: TALK) to be a compelling opportunity. With a market capitalization of..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93.96% Potential Upside in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is emerging as a noteworthy player in the biotechnology sector, capturing investor interest with its promising pipeline and substantial potential upside..

Sionna Therapeutics (SION) Stock Analysis: Evaluating a 27% Potential Upside in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION), a notable player in the biotechnology sector, is making waves with its ambitious approach to treating cystic fibrosis (CF). With a..

COMPASS Pathways Plc (CMPS): Analyst Ratings Suggest a 202% Upside in Psychedelic Therapy Stock

Investors looking for groundbreaking opportunities in the healthcare sector might find COMPASS Pathways Plc (NASDAQ: CMPS) intriguing. Known for its pioneering work in psychedelic therapies, particularly..

Definitive Healthcare Corp. (DH) Stock Analysis: Unpacking the 99% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) is positioning itself as an intriguing opportunity for investors willing to navigate the complexities of the health information services sector. With..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking the 120% Upside Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its promising pipeline dedicated to addressing unmet medical needs...

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Biotech Innovator with a 47.66% Potential Upside

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising developments in precision medicine. Specializing in fibroblast..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 17.95% Potential Upside in a Challenging Healthcare Sector

Community Health Systems, Inc. (NYSE: CYH) presents a complex investment landscape for those interested in the healthcare sector, particularly within the medical care facilities industry. As..

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a 258.65% Potential Upside

In the dynamic world of healthcare technology, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a notable contender within the medical devices industry. Headquartered in Santa Clara,..

Day One Biopharmaceuticals, Inc. (DAWN): A Stock with Over 116% Potential Upside – Investor Outlook

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the biotechnology industry with its innovative approach to tackling both childhood and adult diseases. With a market..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 67.73% Potential Upside in the Cannabis Sector

Investors looking to diversify their portfolios with a stake in the burgeoning cannabis industry might find Tilray Brands, Inc. (TLRY) an intriguing prospect. As a prominent..

Claritev Corporation (CTEV) Stock Analysis: Unveiling 122.76% Potential Upside for Investors

Claritev Corporation (CTEV), a pivotal player in the healthcare sector, is drawing significant attention from investors with its compelling potential upside. With a market capitalization of..

Keros Therapeutics (KROS) Stock Analysis: A Promising Prospect with 36% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS) presents a compelling investment opportunity within the biotechnology sector, marked by a notable 36.31% potential upside, according to current analyst ratings...

AxoGen, Inc. (AXGN) Stock Analysis: Exploring the 10.13% Potential Upside with Strong Buy Ratings

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is currently capturing the attention of individual investors with its innovative..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a 54.96% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) stands out in the biotechnology sector, capturing the attention of investors with a market cap of $2.01 billion and a promising..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenging Valuations

Sonida Senior Living, Inc. (SNDA) stands as a notable player within the healthcare sector, specifically focusing on medical care facilities in the United States. With a..

LifeMD, Inc. (LFMD) Stock Analysis: Discovering a Potential 233.94% Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth provider poised for significant growth. With its market cap standing at..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring an 83% Potential Upside in Biotech Innovation

Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors within the biotechnology sector, primarily due to its promising pipeline and significant potential upside. As..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges and Opportunities in Healthcare Staffing

AMN Healthcare Services Inc (AMN) is a prominent player in the U.S. medical care facilities industry, providing a range of workforce solutions and staffing services to..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds